Inclusion criteria | |
1. Diagnosis of acute bronchitis | |
2. Phlegm-heat obstructing lungs syndrome in traditional Chinese medicine Zheng | |
3. Total cough symptom score ≥ 4 points | |
4. Expectoration in traditional Chinese medicine symptom score ≥ 6 points | |
5. Bronchitis severity score ≥ 6 points | |
6. Disease course within 72 h | |
7. Aged 18 to 65 years old | |
8. Voluntarily provide written and informed consent | |
Exclusion criteria | |
1. Patients with respiratory diseases such as chronic obstructive pulmonary disease, bronchiectasis, asthma, lung cancer, tuberculosis, pneumonia, lung abscess, and chest X-ray showing lung inflammation lesions | |
2. Patients with severe underlying cardiac, cerebral, hematological, hepatic, or renal disorders or other diseases significantly affecting the survival and prognosis, such as cancer | |
3. Current smokers or recent ex-smokers quitting smoking less than 1 month ago | |
4. Use of an angiotensin-converting enzyme inhibitor in the last 1 month | |
5. Patients with body temperature ≥ 38.5 °C | |
6. ALT or AST > 1.5 times of normal upper limit, urine protein >+, serum creatine abnormality, white blood cell count < 3 × 109/L or > 10 × 109/L, and/or neutrophil granulocyte > 80%, or those who need antibiotic therapy | |
7. Those who have used other medicines after disease onset including antibiotics, expectorants, antitussives, systemic or inhaled corticosteroids, inhaled bronchodilators, Chinese medicines of relieving exterior syndrome with pungent-cool drugs, clearing away heat, and detoxification and other related Chinese medicines | |
8. Pregnant or lactating women and those who have pregnancy plans in the last 3 months | |
9. Allergic constitution or known to be allergic to any ingredients in tested drug | |
10. Mental patients or legal disability | |
11. Patients who have participated or are currently participating in another clinical trial in the last 1 month | |
12. Patients who are inappropriate for participation judged by researchers |